Can stillbirth be prevented? Investigating this question, researchers at Inselspital and the Society for the Investigation of Early Pregnancy have discovered a potential prevention mechanism for preterm deliveries.
Inflammatory response during pregnancy is the leading cause of preterm loss. Depending on its degree, it may also lead to preterm birth. A team of researchers from Bern and Rome in cooperation with BioIncept Inc. found that a synthetic version of the PreImplantation Factor (PIF), endogenously present in viable embryos, reduces the inflammatory response during pregnancy. The study results were published in the June 12 issue of PLOS One.
“PIF modulates key elements of the inflammatory pathway namely the inflammasome complex,” explains corresponding author PD Dr. Martin Mueller, Senior Attending in the Department of Gynaecology and Obstetrics at Inselspital, Bern University Hospital, and Visiting Assistant Professor in the Department of Obstetrics, Gynaecology and Reproductive Sciences at Yale School of Medicine. “This mechanism is the first to allow influencing inflammatory response during pregnancy.”
Using a model, Mueller and the team found that PIF reduces foetal loss, reverses the inflammatory response and improves fetal growth. A series of clinically relevant in vivo and in vitro experiments demonstrated that PIF modulates the inflammasome complex in the placenta.
Lead author Nicoletta Di Simone, Professor in the Department of Obstetrics and Gynaecology at Università Cattolica Del Sacro Cuore in Rome, was astonished at the results: “In summary, our findings suggest that PIF protects the pregnancy against an inflammatory insult.”
“This novel pathway is promising and encourages us to pursue this new line of investigation,” said co-author Dr. Daniel Surbek, Professor and Head of the Department of Gynaecology and Obstetrics and feto-maternal medicine at Inselspital. “Given the common inflammatory origin of fetal loss and preterm birth, we may even have a new powerful treatment to prevent both,” he says.
PIF was first discovered and characterized by Eytan Barnea, founder of the Society for the Investigation of Early Pregnancy (SIEP) and chief scientific officer at BioIncept, LLC. Based on his data, the FDA has awarded PIF fast-track designation, resulting in a recently completed first clinical trial to treat patients with autoimmune liver disease at the University of Miami.
In Bern, the research team is now evaluating the possibility of a clinical trial with pregnant subjects. The goal would be to use PIF prophylactically to prevent preterm birth in high-risk pregnancies.
PD Dr. Dr. med. Martin Müller, Senior Attending in the Department of Gynaecology and Obstetrics at Inselspital, Bern University Hospital, contact via firstname.lastname@example.org, +41 31 632 79 25.
Monika Kugemann | idw - Informationsdienst Wissenschaft
Hot cars can hit deadly temperatures in as little as one hour
24.05.2018 | Arizona State University
3D images of cancer cells in the body: Medical physicists from Halle present new method
16.05.2018 | Martin-Luther-Universität Halle-Wittenberg
The more electronics steer, accelerate and brake cars, the more important it is to protect them against cyber-attacks. That is why 15 partners from industry and academia will work together over the next three years on new approaches to IT security in self-driving cars. The joint project goes by the name Security For Connected, Autonomous Cars (SecForCARs) and has funding of €7.2 million from the German Federal Ministry of Education and Research. Infineon is leading the project.
Vehicles already offer diverse communication interfaces and more and more automated functions, such as distance and lane-keeping assist systems. At the same...
A research team led by physicists at the Technical University of Munich (TUM) has developed molecular nanoswitches that can be toggled between two structurally different states using an applied voltage. They can serve as the basis for a pioneering class of devices that could replace silicon-based components with organic molecules.
The development of new electronic technologies drives the incessant reduction of functional component sizes. In the context of an international collaborative...
At the LASYS 2018, from June 5th to 7th, the Laser Zentrum Hannover e.V. (LZH) will be showcasing processes for the laser material processing of tomorrow in hall 4 at stand 4E75. With blown bomb shells the LZH will present first results of a research project on civil security.
At this year's LASYS, the LZH will exhibit light-based processes such as cutting, welding, ablation and structuring as well as additive manufacturing for...
There are videos on the internet that can make one marvel at technology. For example, a smartphone is casually bent around the arm or a thin-film display is rolled in all directions and with almost every diameter. From the user's point of view, this looks fantastic. From a professional point of view, however, the question arises: Is that already possible?
At Display Week 2018, scientists from the Fraunhofer Institute for Applied Polymer Research IAP will be demonstrating today’s technological possibilities and...
So-called quantum many-body scars allow quantum systems to stay out of equilibrium much longer, explaining experiment | Study published in Nature Physics
Recently, researchers from Harvard and MIT succeeded in trapping a record 53 atoms and individually controlling their quantum state, realizing what is called a...
25.05.2018 | Event News
02.05.2018 | Event News
13.04.2018 | Event News
25.05.2018 | Event News
25.05.2018 | Machine Engineering
25.05.2018 | Life Sciences